Get started
Work

A pilot study of sirolimus (S) in subjects with Cowden syndrome (CS) with germ-line mutations in PTEN.

Year: 2013
Type: conference-abstract
DOI: 10.1200/jco.2013.31.15_suppl.2532
Authors: Takefumi Komiya, Gideon Michael Blumenthal, Marc S. Ballas, Roopa Dechowdhury, Michell Manu, Suzanne Fioravanti, Thomas J Hornyak, Stephen Wank, Douglas Weinstein, Jennifer Morris, Stephen M. Hewitt, Regan Memmott, Phillip A. Dennis, Betsy Morrow
Institutions: National Institutes of Health, National Cancer Institute, United States Food and Drug Administration, Bristol-Myers Squibb (United States), Maryland Oncology Hematology, University of Maryland, Baltimore, National Institute of Diabetes and Digestive and Kidney Diseases, Center for Cancer Research, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Open Access status: closed
OpenAlex ID: W2739787702
Cites:
Cited by: 9
Related to: 10